mds highlights at ash: refined prognostication tools and novel combination therapies
Published 2 years ago • 95 plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
2:09
trends in aml and mds at ash 2021
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:40
highlights in lr-mds at the ash 2023 meeting
-
1:27
exciting updates in higher-risk mds at ash 2022
-
1:11
highlights in mds from ash 2018
-
1:14
insights into the management of mds/mpn overlap syndromes & advice for clinicians
-
2:04
eha and asco 2023 highlights: promising treatments in aml, mds, and all
-
1:29
ongoing studies in hr-mds: verona and select mds-1
-
3:02
highlights in aml and mds from eha 2022
-
1:13
the main treatment goals in lr-mds and how these differ from hr-mds
-
2:04
state-of-the-art treatment for hr-mds
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
3:51
mpns highlights at ash 2020
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
2:00
key updates in mds from ash on magrolimab, sabatolimab, venetoclax & tamibarotene
-
2:00
key mds updates from the 2021 ash meeting
-
1:16
state of the art: mds